(NasdaqGM:BCAX), Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW dose Data inform and advance progress toward dose selection for ongoing pivotal FORTIFI-HN01 clinical trial of ficerafusp alfa in combination with pembrolizumab in 1L HPV-negative R/M HNSCC Company to host conference call and webcast […]

(TSX-V:IVS), TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to report the results from its 007 North bulk sample at its wholly-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario. Highlights A total of 427 ounces of gold recovered from 4,674 dry tonnes

(Euronext Amsterdam:TOM2), AMSTERDAM, Dec. 01, 2025 (GLOBE NEWSWIRE) — TomTom (TOM2), the location technology specialist, today released a new report examining how road congestion around major U.S. airports shifts during the country's busiest travel periods, including the recent federal shutdown that stretched across November and contributed to widespread flight cancellations. Drawing on multi-year data across

(NASDAQ:SEER), REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature Genetics of a large genome-wide association study (GWAS) that used the company's Proteograph(R) Product Suite to measure proteins at peptide-level resolution and map their genetic

(NASDAQ:CGEM), Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad population of AML patients CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases

(NasdaqGM:GUTS), BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating

(NASDAQ:SNDX), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET. A live webcast

GRAND RAPIDS, Mich., Dec. 01, 2025 (GLOBE NEWSWIRE) — Edustaff, a leading provider of K-12 educational staffing solutions, is proud to announce a new partnership with Holmdel Township Public Schools in New Jersey. This collaboration marks another key milestone in Edustaff's continued expansion across the state, supporting schools with high-quality substitute and support staff. Through

Barrick Announces Evaluation of an Initial Public Offering of its North American Gold Assets GlobeNewswire December 01, 2025 Contemplated IPO to highlight the value of North American gold assets by creating a focused publicly traded equity (“NewCo”) Barrick would maintain a significant controlling interest in NewCo Company will update market on progress at Full Year

ADC Outsourcing Services Market Forecast: USD 2.94 Billion in 2025 to USD 5.19 Billion by 2034 The global ADC outsourcing service market size was valued at USD 2.76 billion in 2024 and is predicted to hit around USD 5.19 billion by 2034, rising at a 6.52% CAGR, a study published by Towards Healthcare a sister